1537 related articles for article (PubMed ID: 16338213)
1. Alopecia areata: a tissue specific autoimmune disease of the hair follicle.
Gilhar A; Kalish RS
Autoimmun Rev; 2006 Jan; 5(1):64-9. PubMed ID: 16338213
[TBL] [Abstract][Full Text] [Related]
2. Autoimmune hair loss (alopecia areata) transferred by T lymphocytes to human scalp explants on SCID mice.
Gilhar A; Ullmann Y; Berkutzki T; Assy B; Kalish RS
J Clin Invest; 1998 Jan; 101(1):62-7. PubMed ID: 9421466
[TBL] [Abstract][Full Text] [Related]
3. Lymphocytes, neuropeptides, and genes involved in alopecia areata.
Gilhar A; Paus R; Kalish RS
J Clin Invest; 2007 Aug; 117(8):2019-27. PubMed ID: 17671634
[TBL] [Abstract][Full Text] [Related]
4. Interferon-gamma-deficient mice are resistant to the development of alopecia areata.
Freyschmidt-Paul P; McElwee KJ; Hoffmann R; Sundberg JP; Vitacolonna M; Kissling S; Zöller M
Br J Dermatol; 2006 Sep; 155(3):515-21. PubMed ID: 16911275
[TBL] [Abstract][Full Text] [Related]
5. Alopecia areata: autoimmunity--the evidence is compelling.
Kalish RS; Gilhar A
J Investig Dermatol Symp Proc; 2003 Oct; 8(2):164-7. PubMed ID: 14582666
[TBL] [Abstract][Full Text] [Related]
6. Melanocyte-associated T cell epitopes can function as autoantigens for transfer of alopecia areata to human scalp explants on Prkdc(scid) mice.
Gilhar A; Landau M; Assy B; Shalaginov R; Serafimovich S; Kalish RS
J Invest Dermatol; 2001 Dec; 117(6):1357-62. PubMed ID: 11886495
[TBL] [Abstract][Full Text] [Related]
7. Alopecia areata: autoimmune basis of hair loss.
Alexis AF; Dudda-Subramanya R; Sinha AA
Eur J Dermatol; 2004; 14(6):364-70. PubMed ID: 15564197
[TBL] [Abstract][Full Text] [Related]
8. Expression of vascular endothelial growth factor, apoptosis inhibitors (survivin and p16) and CCL27 in alopecia areata before and after diphencyprone treatment: an immunohistochemical study.
Simonetti O; Lucarini G; Bernardini ML; Simoncini C; Biagini G; Offidani A
Br J Dermatol; 2004 May; 150(5):940-8. PubMed ID: 15149507
[TBL] [Abstract][Full Text] [Related]
9. An update on alopecia areata.
Kos L; Conlon J
Curr Opin Pediatr; 2009 Aug; 21(4):475-80. PubMed ID: 19502982
[TBL] [Abstract][Full Text] [Related]
10. Alopecia areata: a review of disease pathogenesis.
Rajabi F; Drake LA; Senna MM; Rezaei N
Br J Dermatol; 2018 Nov; 179(5):1033-1048. PubMed ID: 29791718
[TBL] [Abstract][Full Text] [Related]
11. Type 1 interferon signature in the scalp lesions of alopecia areata.
Ghoreishi M; Martinka M; Dutz JP
Br J Dermatol; 2010 Jul; 163(1):57-62. PubMed ID: 20346028
[TBL] [Abstract][Full Text] [Related]
12. Is alopecia areata an autoimmune-response against melanogenesis-related proteins, exposed by abnormal MHC class I expression in the anagen hair bulb?
Paus R; Slominski A; Czarnetzki BM
Yale J Biol Med; 1993; 66(6):541-54. PubMed ID: 7716973
[TBL] [Abstract][Full Text] [Related]
13. CXCL10 produced from hair follicles induces Th1 and Tc1 cell infiltration in the acute phase of alopecia areata followed by sustained Tc1 accumulation in the chronic phase.
Ito T; Hashizume H; Shimauchi T; Funakoshi A; Ito N; Fukamizu H; Takigawa M; Tokura Y
J Dermatol Sci; 2013 Feb; 69(2):140-7. PubMed ID: 23312578
[TBL] [Abstract][Full Text] [Related]
14. Melanocytes: a possible autoimmune target in alopecia areata.
Trautman S; Thompson M; Roberts J; Thompson CT
J Am Acad Dermatol; 2009 Sep; 61(3):529-30. PubMed ID: 19700020
[No Abstract] [Full Text] [Related]
15. Alopecia areata is a T-lymphocyte mediated autoimmune disease: lesional human T-lymphocytes transfer alopecia areata to human skin grafts on SCID mice.
Gilhar A; Shalaginov R; Assy B; Serafimovich S; Kalish RS
J Investig Dermatol Symp Proc; 1999 Dec; 4(3):207-10. PubMed ID: 10674367
[TBL] [Abstract][Full Text] [Related]
16. Normalisation of hair follicle morphology in C3H/HeJ alopecia areata mice after treatment with squaric acid dibutylester.
Gardner S; Freyschmidt-Paul P; Hoffmann R; Sundberg JP; Happle R; Lindsey NJ; Tobin DJ
Eur J Dermatol; 2000 Aug; 10(6):443-50. PubMed ID: 10980465
[TBL] [Abstract][Full Text] [Related]
17. Male New Zealand Black/KN mice: a novel model for autoimmune-induced permanent alopecia?
Hiroi A; Ito T; Seo N; Uede K; Yoshimasu T; Ito M; Nakamura K; Ito N; Paus R; Furukawa F
Br J Dermatol; 2006 Aug; 155(2):437-45. PubMed ID: 16882186
[TBL] [Abstract][Full Text] [Related]
18. Alopecia areata: Animal models illuminate autoimmune pathogenesis and novel immunotherapeutic strategies.
Gilhar A; Schrum AG; Etzioni A; Waldmann H; Paus R
Autoimmun Rev; 2016 Jul; 15(7):726-35. PubMed ID: 26971464
[TBL] [Abstract][Full Text] [Related]
19. Transfer of alopecia areata in the human scalp graft/Prkdc(scid) (SCID) mouse system is characterized by a TH1 response.
Gilhar A; Landau M; Assy B; Ullmann Y; Shalaginov R; Serafimovich S; Kalish RS
Clin Immunol; 2003 Mar; 106(3):181-7. PubMed ID: 12706404
[TBL] [Abstract][Full Text] [Related]
20. Substance P as an immunomodulatory neuropeptide in a mouse model for autoimmune hair loss (alopecia areata).
Siebenhaar F; Sharov AA; Peters EM; Sharova TY; Syska W; Mardaryev AN; Freyschmidt-Paul P; Sundberg JP; Maurer M; Botchkarev VA
J Invest Dermatol; 2007 Jun; 127(6):1489-97. PubMed ID: 17273166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
